WuXi Biologics Ranked Top 1% Globally in S&P Sustainability Yearbook for Fourth Consecutive Year
WuXi Biologics has been ranked first in its industry and placed in the Top 1% globally in the S&P Global Sustainability Yearbook 2026, following strong performance in the 2025 Corporate Sustainability Assessment (CSA). The recognition marks the fourth consecutive year that the global Contract Research, Development and Manufacturing Organization (CRDMO) has achieved this highest distinction. […]



